R&D Outsourcing Could Make China, India Pharma Giants

The practice of multinational pharmaceuticals of outsourcing research and development is helping to build China and India into major producers of intellectual property products as they develop novel drugs. The author of a study on the impact of R&D in China and India said the two countries are rapidly developing scientists with the ability to innovate in the pharma field, faster than would have been imagined five years ago. Because most risk-sharing agreements with foreign drug makers are less than four years old, concrete results from all the work may not be known for another decade, he said, given the time required to bring a drug to market. (Click here for more